Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07071207 · ClinicalTrials.gov registry record · NA
Effect of Text Message Reminders on M-ISI Score After Prostate Surgery
A NA study of Prostate Cancer and Benign Prostate Hyperplasia, sponsored by University of Rochester.
- Recruiting
- Registry status
- NA
- Development phase
- 132
- Enrollment target
- 1
- Study location
NCT07071207: Recruiting NA study of Prostate Cancer and Benign Prostate Hyperplasia, sponsored by University of Rochester.
NCT07071207 is a NA study of Prostate Cancer and Benign Prostate Hyperplasia that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 132 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07071207, a NA study of Prostate Cancer and Benign Prostate Hyperplasia, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare post-prostatectomy incontinence via Michigan Incontinence Score Index in patients receiving daily text message reminders for pelvic floor exercises when compared to those not receiving text reminders.
Primary Outcome
The time it takes for participants to recover continence, as defined by two successive M-ISI Pad Use Subdomain Scores of ≤ 2. The Pad Use Subdomain Score is determined by the sum of items Q7-8 from the M-ISI questionnaire, assessed as a time-to-event outcome.
Conditions Studied
Interventions
- BEHAVIORAL Text message reminders
Study Locations (1)
New York
- 158 Sawgrass clinic; Suite 3100 - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2025-09-15 |
| Est. Completion | 2028-05-01 |
| Phase | NA |
What NCT07071207 shows while recruiting
NCT07071207 is an interventional study that assigns participants to a tested intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (78% lower).
The record links to 3 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Text message reminders is the first listed.
NCT07071207 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07071207 about?
NCT07071207 is a clinical study titled "Effect of Text Message Reminders on M-ISI Score After Prostate Surgery". The purpose of this study is to compare post-prostatectomy incontinence via Michigan Incontinence Score Index in patients receiving daily text message reminders for pelvic floor exercises when compared to those not receiving text reminders.
What is the current status of trial NCT07071207?
This trial is currently recruiting. It is a NA study. The enrollment target is 132 participants. The study started on 2025-09-15. Estimated completion is 2028-05-01.
What conditions does trial NCT07071207 study?
This clinical trial studies the following conditions: Prostate Cancer, Benign Prostate Hyperplasia, Incontinence, Urinary Stress.
What interventions are being tested in trial NCT07071207?
The interventions under investigation include: Text message reminders (BEHAVIORAL).
Who is sponsoring clinical trial NCT07071207?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07071207 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07071207's enrollment target sits among peer trials
132 288th of 735 higher than 447 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI